Shares of Elevance Health have moved -1.2% today, and are now trading at a price of $492.07. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 1,209,195 compared to the stock's average volume of 1,011,064.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. Based in Indianapolis, United States the company has 104,900 full time employees and a market cap of $114,104,147,968. Elevance Health currently offers its equity investors a dividend that yields 1.2% per year.
The company is now trading -18.34% away from its average analyst target price of $602.6 per share. The 19 analysts following the stock have set target prices ranging from $552.31 to $665.0, and on average give Elevance Health a rating of buy.
Over the last 52 weeks, ELV stock has risen 8.6%, which amounts to a -24.0% difference compared to the S&P 500. The stock's 52 week high is $567.26 whereas its 52 week low is $435.99 per share. With its net margins declining an average -2.2% over the last 6 years, Elevance Health may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 171,340,000 | 5,987,000 | 3 | -25.0 |
| 2022 | 156,595,000 | 5,894,000 | 4 | 0.0 |
| 2021 | 138,639,000 | 6,158,000 | 4 | 0.0 |
| 2020 | 121,867,000 | 4,572,000 | 4 | -20.0 |
| 2019 | 104,213,000 | 4,807,000 | 5 | 25.0 |
| 2018 | 92,105,000 | 3,750,000 | 4 |
